Target Name: ATP5MC1
NCBI ID: G516
Review Report on ATP5MC1 Target / Biomarker Content of Review Report on ATP5MC1 Target / Biomarker
ATP5MC1
Other Name(s): mitochondrial ATP synthase, subunit 9 | ATP synthase proteolipid P1 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9) | ATP synthase lipid-binding protein, mitochondrial | ATP synthase F(0) complex subunit C1, mitochondrial | ATP synthase subunit 9 | Mitochondrial ATP synthase, subunit C, isoform 1 | ATP5MC1 variant 1 | ATP5A | ATPase subunit C | ATP synthase lipid-binding protein | ATP synthase membrane subunit c locus 1, transcript variant 1 | mitochondrial ATP synthase, subunit C | ATP5G | ATP synthase, H+ transporting, mitochondrial Fo complex subunit C1 (subunit 9) | ATP synthase membrane subunit c locus 1 | ATPase subunit 9 | AT5G1_HUMAN | Mitochondrial ATP synthase, subunit 9, isoform 1 | ATPase protein 9 | dicyclohexylcarbodiimide (DCCD)-reactive proteolipid subunit | ATPase subunit c | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9) | ATP5G1 | ATP synthase proton-transporting mitochondrial F(0) complex subunit C1 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9), isoform 1

ATP5MC1: Mitochondrial ATP Synthase Subunit 9

ATP5MC1, also known as mitochondrial ATP synthase subunit 9, is a protein that plays a crucial role in the production of ATP in the mitochondria. It is a subunit of the mitochondrial ATP synthase, which is a complex protein that uses ATP as its energy source to produce ATP through a process called chemiosmosis. ATP is a vital energy source for the cell, and its production is essential for the proper functioning of many cellular processes.

ATP5MC1 is a 21-kDa protein that is expressed in the mitochondria of most eukaryotic cells. It is composed of 116 amino acids and has a calculated pI of 12.5. ATP5MC1 is primarily localized to the mitochondria, but can also be found in the cytoplasm of the cells. It is a monomer and has a single transmembrane domain.

ATP5MC1 is involved in the production of ATP through the chemiosmosis process. In this process, ATP5MC1 is part of the active site, which is the region of the protein that catalyzes the production of ATP. The active site is composed of several subunits, including subunit 1, subunit 2, subunit 3, subunit 4, and subunit 5. These subunits work together to facilitate the production of ATP through the chemiosmosis process.

ATP5MC1 plays a crucial role in the production of ATP in the mitochondria. It is the only known protein that is responsible for the production of ATP through the chemiosmosis process. Subunit 1 of ATP5MC1 is responsible for the production of the high-energy electrons that are used to produce ATP. Subunit 2 is responsible for the production of the ammonium ions that are used to activate the ATP synthase. Subunit 3 is responsible for the production of the phosphate ions that are used to activate the ATP synthase. Subunit 4 is responsible for the production of the carbon dioxide that is used to produce ATP through the citric acid cycle. Subunit 5 is responsible for the production of the water that is used to produce ATP through the citric acid cycle.

ATP5MC1 is a potential drug target for the treatment of various diseases. For example, it has been shown to be involved in the production of ATP, which is essential for the proper functioning of many cellular processes. Therefore, inhibiting the production of ATP through ATP5MC1 may be a useful strategy for the treatment of diseases that are caused by the overproduction or decreased production of ATP.

In addition to its role in the production of ATP, ATP5MC1 may also be a biomarker for certain diseases. For example, ATP5MC1 has been shown to be decreased in individuals with certain forms of cancer, such as lung cancer. Therefore, measuring the levels of ATP5MC1 in cancer cells may be a useful diagnostic tool for the detection of certain forms of cancer.

In conclusion, ATP5MC1 is a protein that plays a crucial role in the production of ATP in the mitochondria. It is a subunit of the mitochondrial ATP synthase and is involved in the chemiosmosis process. ATP5MC1 is a potential drug target and may also be a biomarker for certain diseases. Further research is needed to fully understand the role of ATP5MC1 in cellular processes and its potential as a drug or biomarker.

Protein Name: ATP Synthase Membrane Subunit C Locus 1

Functions: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain. A homomeric c-ring of probably 10 subunits is part of the complex rotary element

The "ATP5MC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ATP5MC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ATP5MC1P3 | ATP5MC2 | ATP5MC3 | ATP5ME | ATP5MF | ATP5MG | ATP5MGL | ATP5MJ | ATP5MK | ATP5PB | ATP5PBP5 | ATP5PD | ATP5PDP3 | ATP5PF | ATP5PO | ATP6 | ATP6AP1 | ATP6AP1-DT | ATP6AP1L | ATP6AP2 | ATP6V0A1 | ATP6V0A2 | ATP6V0A4 | ATP6V0B | ATP6V0C | ATP6V0CP1 | ATP6V0CP3 | ATP6V0D1 | ATP6V0D1-DT | ATP6V0D2 | ATP6V0E1 | ATP6V0E1P1 | ATP6V0E2 | ATP6V0E2-AS1 | ATP6V1A | ATP6V1B1 | ATP6V1B2 | ATP6V1C1 | ATP6V1C2 | ATP6V1D | ATP6V1E1 | ATP6V1E2 | ATP6V1F | ATP6V1FNB | ATP6V1G1 | ATP6V1G1P1 | ATP6V1G2 | ATP6V1G2-DDX39B | ATP6V1G3 | ATP6V1H | ATP7A | ATP7B | ATP8 | ATP8A1 | ATP8A2 | ATP8B1 | ATP8B1-AS1 | ATP8B2 | ATP8B3 | ATP8B4 | ATP8B5P | ATP9A | ATP9B | ATPAF1 | ATPAF2 | ATPase | ATPSCKMT | ATR | ATRAID | Atrial natriuretic peptide (ANP) receptor | ATRIP | ATRN | ATRNL1 | ATRX | ATXN1 | ATXN10 | ATXN1L | ATXN2 | ATXN2L | ATXN3 | ATXN3L | ATXN7 | ATXN7L1 | ATXN7L2 | ATXN7L3 | ATXN7L3B | ATXN8OS | Augmin | AUH | AUNIP | AUP1 | AURKA | AURKAIP1 | AURKAP1 | AURKB | AURKC | Aurora Kinase | AUTS2 | AVEN | AVIL